PTGS2 and cystic fibrosis: Withaferin-A is effective in treating various inflammatory conditions in diseases such as inflammation associated with arthritis, cystic fibrosis, and inflammatory bowel disease by different mechanisms like inhibiting nuclear factor kappa B (NF-κB) activation, and inhibition of cyclooxygenase-2 (COX-2) generation.